过去一年中添加的文章,按日期排序

[HTML][HTML] Male Reproduction in Spinal Muscular Atrophy (SMA) and the Potential Impact of Oral Survival of Motor Neuron 2 (SMN2) Pre-mRNA Splicing Modifiers

N Bar-Chama, B Elsheikh, C Hewamadduma… - … and Therapy, 2024 - Springer
12 天前 - … Spinal muscular atrophy (SMA) is a neuromuscular disease caused by deletions
or mutations in the survival of motor neuron 1 (SMN1) gene resulting in reduced levels of SMN …

Challenges and opportunities in spinal muscular atrophy therapeutics

CJJ Yeo, EF Tizzano, BT Darras - The Lancet Neurology, 2024 - thelancet.com
126 天前 - … , gene replacement therapy with onasemnogene abeparvovec, and the small-molecule
splicing modifier … in infants and children with spinal muscular atrophy. Given the lifelong …

[HTML][HTML] Gene replacement therapy in spinal muscular atrophy: filling the data gaps

T Hagenacker, U Schara-Schmidt - The Lancet Regional Health …, 2024 - thelancet.com
158 天前 - … The genetically-based therapy of spinal muscular atrophy (… development of therapies
for hereditary neuromuscular … splicing modifiers nusinersen and risdiplam and the gene

To examine the role of a nuclear import protein karyopherin-β2 in FUS-mediated amyotrophic lateral sclerosis pathogenesis

CP Zammerilla - 2023 - d-scholarship.pitt.edu
278 天前 - … that KAPβ2 is a modifier of FUS-induced ALS in Drosophila neurons. As KAPβ2 is
a modifier of FUS-mediated ALS KAPβ2 could be used as a possible therapeutic for ALS. The …

Is it time for genetic modifiers to predict prognosis in Duchenne muscular dystrophy?

L Bello, EP Hoffman, E Pegoraro - Nature Reviews Neurology, 2023 - nature.com
351 天前 - genetic modifier studies in DMD to date and discusses the effect of genetic modifiers
on … (inclusion of genotype-stratified subgroup analyses) and therapeutic approaches. The …